Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bakris

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Acta Pharmacologica Et Toxicologica|November 1, 1982
A liquid chromatographic assay for 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in human body fluidsB Petruccelli, G Bakris, T Miller, et al.
Diabetes, Obesity & Metabolism|September 30, 2011
Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO studyI Lazich, P Sarafidis, E de Guzman, et al.
Journal of Human Hypertension|February 7, 2003
Rosiglitazone reduces urinary albumin excretion in type II diabetesG Bakris, G Viberti, W M Weston, et al.
Journal of Human Hypertension|January 26, 2007
Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot studyG Bakris, M Dickholtz, P M Meyer, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM studyG Bakris, A Gradman, M Reif, et al.
Diabetes, Obesity & Metabolism|March 8, 2013
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney diseaseJ-F Yale, G Bakris, B Cariou, et al.
Diabetes, Obesity & Metabolism|June 27, 2014
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney diseaseJ-F Yale, G Bakris, B Cariou, et al.
Journal of Internal Medicine|November 29, 2014
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studiesM Böhm, H Schumacher, R E Schmieder, et al.
Circulation|March 26, 2008
N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK)B C Astor, S Yi, L Hiremath, et al.
Journal of Human Hypertension|August 31, 2007
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to actionG Bakris, M Hill, G Mancia, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Acta Pharmacologica Et Toxicologica|November 1, 1982
A liquid chromatographic assay for 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in human body fluidsB Petruccelli, G Bakris, T Miller, et al.
Diabetes, Obesity & Metabolism|September 30, 2011
Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO studyI Lazich, P Sarafidis, E de Guzman, et al.
Journal of Human Hypertension|February 7, 2003
Rosiglitazone reduces urinary albumin excretion in type II diabetesG Bakris, G Viberti, W M Weston, et al.
Journal of Human Hypertension|January 26, 2007
Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot studyG Bakris, M Dickholtz, P M Meyer, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM studyG Bakris, A Gradman, M Reif, et al.
Diabetes, Obesity & Metabolism|March 8, 2013
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney diseaseJ-F Yale, G Bakris, B Cariou, et al.
Diabetes, Obesity & Metabolism|June 27, 2014
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney diseaseJ-F Yale, G Bakris, B Cariou, et al.
Journal of Internal Medicine|November 29, 2014
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studiesM Böhm, H Schumacher, R E Schmieder, et al.
Circulation|March 26, 2008
N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK)B C Astor, S Yi, L Hiremath, et al.
Journal of Human Hypertension|August 31, 2007
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to actionG Bakris, M Hill, G Mancia, et al.
Pageof 4